라벨이 Lecanemab A Promising Alzheimer's Treatment Explained인 게시물 표시

Why Was Danielle the Only Member to Leave NewJeans?

이미지
  Why Was Danielle the Only Member to Leave NewJeans? Korean Ver posting ->click Confirmed Returns, Ongoing Talks, and What Happens Next On December 29, 2025, ADOR officially announced a major turning point for the K-pop group NewJeans . While several members decided to return to the agency, Danielle became the only member whose exclusive contract was terminated . This decision immediately raised a key question among fans and industry observers worldwide: Why was Danielle the only member to leave NewJeans? This article breaks down what happened, who has officially returned, and what the future may hold for the group. What Happened Between ADOR and NewJeans? The conflict between NewJeans and their agency ADOR stems from a long-running contractual dispute that escalated into legal action. After the court confirmed the validity of the exclusive contracts , ADOR began individual discussions with each member and their families. These discussions resulted in different decis...

Lecanemab A Promising Alzheimer's Treatment Explained

이미지
Lecanemab A Promising Alzheimer's Treatment Explained Lecanemab, also known under the brand name Leqembi, has emerged as a groundbreaking therapy in the battle against Alzheimer's disease. Recently spotlighted on Korean health TV shows and conditionally approved by the U.S. FDA, this drug is generating widespread attention for its potential to slow cognitive decline. In this post, we'll explore what Lecanemab is, how it works, side effects, comparisons to Aducanumab, and more. Table of Contents 1. What Is Lecanemab? 2. Key Benefits of Lecanemab 3. Important Considerations 4. Side Effects 5. Lecanemab vs. Aducanumab 6. How Lecanemab Is Administered 7. Cost and FAQs 8. Final Thoughts 1. What Is Lecanemab? Lecanemab is an antibody-based drug co-developed by Eisai (Japan) and Biogen (USA) to treat early Alzheimer's disease. It targets beta-amyloid protein buildup in the brain, which is believed to contribute to disease progression. In 2023, ...